Literature DB >> 19700609

Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized.

Stephen Franks1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19700609     DOI： 10.1210/en.2009-0652

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  12 in total

1.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

2.  Increased expression of kindlin 2 in luteinized granulosa cells correlates with androgen receptor level in patients with polycystic ovary syndrome having hyperandrogenemia.

Authors:  Mei Yang; Juan Du; Danyu Lu; Caixia Ren; Huan Shen; Jie Qiao; Xi Chen; Hongquan Zhang
Journal:  Reprod Sci       Date:  2013-12-13       Impact factor: 3.060

3.  Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring.

Authors:  David H Abbott; Cristin R Bruns; Deborah K Barnett; Andrea Dunaif; Theodore L Goodfriend; Daniel A Dumesic; Alice F Tarantal
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-03       Impact factor: 4.310

Review 4.  Hormonal programming across the lifespan.

Authors:  B M Nugent; S A Tobet; H E Lara; A B Lucion; M E Wilson; S E Recabarren; A H Paredes
Journal:  Horm Metab Res       Date:  2012-06-14       Impact factor: 2.936

5.  Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

Authors:  Helen Anderson; Naomi Fogel; Stefan K Grebe; Ravinder J Singh; Robert L Taylor; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

6.  Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats.

Authors:  Fang Wang; Bolan Yu; Wenjing Yang; Jianqiao Liu; Jiachun Lu; Xuefeng Xia
Journal:  J Ovarian Res       Date:  2012-05-18       Impact factor: 4.234

7.  Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.

Authors:  Victoria Tyndall; Marie Broyde; Richard Sharpe; Michelle Welsh; Amanda J Drake; Alan S McNeilly
Journal:  Reproduction       Date:  2011-10-20       Impact factor: 3.906

Review 8.  Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction.

Authors:  Julia Johansson; Elisabet Stener-Victorin
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-02       Impact factor: 2.629

9.  Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.

Authors:  Joseph S Marino; Jeffrey Iler; Abigail R Dowling; Streamson Chua; Jens C Bruning; Roberto Coppari; Jennifer W Hill
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

Review 10.  Complementary therapy in polycystic ovary syndrome.

Authors:  C I Aquino; S L Nori
Journal:  Transl Med UniSa       Date:  2014-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.